Radiopharm Theranostics Ltd secures brain tumour-targeting technology for clinical pipeline portfolio
June 9th, 2022 | 🕒
iSpeech.org Radiopharm Theranostics Ltd (ASX:RAD) has sublicensed a promising imaging and therapeutic radiopharmaceutical technology created by the Case Western Reserve
Gloss